Breaking news:
PM Modi Emphasizes Harmony in Eid Greetings, Rahul Gandhi Calls for Peace | Four Chinese Men Detained After Fleeing Bangkok Collapse Site With Documents | PM Modi Makes First Visit to RSS Headquarters Since Taking Office | Trump Says He’s Seriously Considering a Third Term
Logo

Union Health Secretary Visits Pharmaceutical Bilthoven Biologicals, Netherlands; Has Engaging Meeting With CEO

Discusses partnership and collaboration on production of vaccines, especially Oral Polio Vaccine 

28-04-2024
image
   

Union Health Secretary Apurva Chandra today visited the manufacturing unit of global pharmaceutical company Bilthoven Biologicals at Utrecht, Netherlands. He had an engaging meeting with CEO Juergen Kwik & CEO of Poonawalla Science Park (PSP) at Bilthoven Jef De Clercq on EU pandemic preparedness partnership and collaboration on production of vaccines. He met the senior management and was briefed on the various manufacturing units of the facility. A detailed presentation was made on their future manufacturing plans. Bilthoven Biologicals B.V. Co., manufactures pharmaceutical products such as vaccines for polio, diphtheria-tetanus-polio, and tetanus along with bacillus calmette-guerin (BCG).

The bioengineering and vaccine production firm Bilthoven Biologicals was purchased by Serum India Ltd., in 2012. This has strengthened its capacity of producing vaccines and also provided it with a valuable manufacturing base in Europe. Recently Serum and Bharat Biotech have announced collaboration for enhanced production of OPV. Bharat Biotech will collaborate with Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Institute of India. An agreement has been signed under which Bharat Biotech will procure drug substances for manufacturing oral polio vaccines to be supplied within India and globally. This will contribute to supply security of oral polio vaccines. With this partnership, the capacity of BBIL to manufacture Oral Polio Vaccine (OPV) has increased to 500 million doses every year. 

Universal Immunisation Programme (UIP) of the Union Health Ministry is one of the key interventions for protection of children from life threatening conditions by providing vaccination, including vaccine against polio.  India has been certified free of Polio in March 2014. However, to maintain the polio-free status, polio vaccine is given to children as part of the high quality national and sub-national polio rounds across the country. A sustained supply of OPV is essential for keeping India polio free. The partnership between BBIL and Serum will contribute to providing a sustained supply of OPV in the country.

Image

Trump’s ‘Liberation Day’ Tariffs: Which Countries Will Be Hit the Harde

US President Donald Trump is set to impose new tariffs on April 2, targeting countries with high tra

Read More
Image

China, Japan, and South Korea Unite to Counter US Tariffs, Explore Trade Pact

China, Japan, and South Korea have agreed to collaborate on supply chains and trade strategies as th

Read More
Image

Trump's ‘Balanced but Firm’ Trade Move: What It Means for India Ahead of

US President Donald Trump plans to introduce new reciprocal tariffs, citing unfair trade practices a

Read More